Comments on: Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy https://insideout.vn/travere-therapeutics-and-csl-vifor-announce-swissmedic-approval-of-filspari-sparsentan-for-the-treatment-of-iga-nephropathy/ Inside Out Thu, 17 Oct 2024 11:21:16 +0000 hourly 1 https://wordpress.org/?v=6.6.2